Literature DB >> 20501694

Role of the renin angiotensin system on bone marrow-derived stem cell function and its impact on skeletal muscle angiogenesis.

Micheline M de Resende1, Timothy J Stodola, Andrew S Greene.   

Abstract

Autologous bone marrow cell (BMC) transplantation has been shown as a potential approach to treat various ischemic diseases. However, under many conditions BMC dysfunction has been reported, leading to poor cell engraftment and a failure of tissue revascularization. We have previously shown that skeletal muscle angiogenesis induced by electrical stimulation (ES) is impaired in the SS/Mcwi rats and that this effect is related to a dysregulation of the renin angiotensin system (RAS) that is normalized by the replacement of chromosome 13 derived from the Brown Norway rat (SS-13(BN)/Mcwi consomic rats). The present study explored bone marrow-derived endothelial cell (BM-EC) function in the SS/Mcwi rat and its impact on skeletal muscle angiogenesis induced by ES. SS/Mcwi rats were randomized to receive BMC from: SS/Mcwi; SS-13(BN)/Mcwi; SS/Mcwi rats infused with saline or ANG II (3 ng kg(-1) min(-1)). BMC were injected in the stimulated tibialis anterior muscle of SS/Mcwi rats. Vessel density was evaluated in unstimulated and stimulated muscles after 7 days of ES. BMC isolated from SS/Mcwi or SS/Mcwi rats infused with saline failed to restore angiogenesis induced by ES. However, BMC isolated from SS-13(BN)/Mcwi and SS/Mcwi rats infused with ANG II effectively restored the angiogenesis response in the SS/Mcwi recipient. Furthermore, ANG II infusion increased the capacity of BM-EC to induce endothelial cell tube formation in vitro and slightly increased VEGF protein expression. This study suggests that dysregulation of the RAS in the SS/Mcwi rat contributes to impaired BM-EC function and could impact the angiogenic therapeutic potential of BMC.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20501694      PMCID: PMC2929886          DOI: 10.1152/physiolgenomics.00037.2010

Source DB:  PubMed          Journal:  Physiol Genomics        ISSN: 1094-8341            Impact factor:   3.107


  63 in total

1.  Microcirculation in hypertension: a new target for treatment?

Authors:  B I Levy; G Ambrosio; A R Pries; H A Struijker-Boudier
Journal:  Circulation       Date:  2001-08-07       Impact factor: 29.690

2.  Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial.

Authors:  Eriko Tateishi-Yuyama; Hiroaki Matsubara; Toyoaki Murohara; Uichi Ikeda; Satoshi Shintani; Hiroya Masaki; Katsuya Amano; Yuji Kishimoto; Kohji Yoshimoto; Hidetoshi Akashi; Kazuyuki Shimada; Toshiji Iwasaka; Tsutomu Imaizumi
Journal:  Lancet       Date:  2002-08-10       Impact factor: 79.321

3.  Origin of endothelial progenitors in human postnatal bone marrow.

Authors:  Morayma Reyes; Arkadiusz Dudek; Balkrishna Jahagirdar; Lisa Koodie; Paul H Marker; Catherine M Verfaillie
Journal:  J Clin Invest       Date:  2002-02       Impact factor: 14.808

4.  Mobilized bone marrow cells repair the infarcted heart, improving function and survival.

Authors:  D Orlic; J Kajstura; S Chimenti; F Limana; I Jakoniuk; F Quaini; B Nadal-Ginard; D M Bodine; A Leri; P Anversa
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-14       Impact factor: 11.205

5.  Angiotensin II and VEGF are involved in angiogenesis induced by short-term exercise training.

Authors:  S L Amaral; P E Papanek; A S Greene
Journal:  Am J Physiol Heart Circ Physiol       Date:  2001-09       Impact factor: 4.733

6.  Combining pharmacological mobilization with intramyocardial delivery of bone marrow cells over-expressing VEGF is more effective for cardiac repair.

Authors:  Yigang Wang; Husnain K Haider; Nauman Ahmad; Meifeng Xu; Ruowen Ge; Muhammad Ashraf
Journal:  J Mol Cell Cardiol       Date:  2006-05       Impact factor: 5.000

7.  Functional small-diameter neovessels created using endothelial progenitor cells expanded ex vivo.

Authors:  S Kaushal; G E Amiel; K J Guleserian; O M Shapira; T Perry; F W Sutherland; E Rabkin; A M Moran; F J Schoen; A Atala; S Soker; J Bischoff; J E Mayer
Journal:  Nat Med       Date:  2001-09       Impact factor: 53.440

Review 8.  Endothelial progenitor cells in cardiovascular disorders.

Authors:  Eduard Shantsila; Timothy Watson; Gregory Y H Lip
Journal:  J Am Coll Cardiol       Date:  2007-02-20       Impact factor: 24.094

9.  Adult hematopoietic stem cells provide functional hemangioblast activity during retinal neovascularization.

Authors:  Maria B Grant; W Stratford May; Sergio Caballero; Gary A J Brown; Steven M Guthrie; Robert N Mames; Barry J Byrne; Timothy Vaught; Polyxenie E Spoerri; Ammon B Peck; Edward W Scott
Journal:  Nat Med       Date:  2002-06       Impact factor: 53.440

10.  Angiotensin II infusion restores stimulated angiogenesis in the skeletal muscle of rats on a high-salt diet.

Authors:  Matthew C Petersen; Diane H Munzenmaier; Andrew S Greene
Journal:  Am J Physiol Heart Circ Physiol       Date:  2006-02-03       Impact factor: 4.733

View more
  16 in total

1.  Angiotensin-converting enzyme (ACE) genotypes and disability in hospitalized older patients.

Authors:  Davide Seripa; Giulia Paroni; Maria G Matera; Carolina Gravina; Carlo Scarcelli; Michele Corritore; Luigi P D'Ambrosio; Maria Urbano; Grazia D'Onofrio; Massimiliano Copetti; Patrick G Kehoe; Francesco Panza; Alberto Pilotto
Journal:  Age (Dordr)       Date:  2010-11-13

2.  Targeting the endothelial progenitor cell surface proteome to identify novel mechanisms that mediate angiogenic efficacy in a rodent model of vascular disease.

Authors:  Catherine C Kaczorowski; Timothy J Stodola; Brian R Hoffmann; Anthony R Prisco; Pengyuan Y Liu; Daniela N Didier; Jamie R Karcher; Mingyu Liang; Howard J Jacob; Andrew S Greene
Journal:  Physiol Genomics       Date:  2013-09-10       Impact factor: 3.107

3.  Neutrophils express oncomodulin and promote optic nerve regeneration.

Authors:  Takuji Kurimoto; Yuqin Yin; Ghaith Habboub; Hui-Ya Gilbert; Yiqing Li; Shintaro Nakao; Ali Hafezi-Moghadam; Larry I Benowitz
Journal:  J Neurosci       Date:  2013-09-11       Impact factor: 6.167

4.  Vascular endothelial growth factor-A signaling in bone marrow-derived endothelial progenitor cells exposed to hypoxic stress.

Authors:  Brian R Hoffmann; Jordan R Wagner; Anthony R Prisco; Agnieszka Janiak; Andrew S Greene
Journal:  Physiol Genomics       Date:  2013-09-10       Impact factor: 3.107

5.  TNF-α increases endothelial progenitor cell adhesion to the endothelium by increasing bond expression and affinity.

Authors:  Anthony R Prisco; Michael R Prisco; Brian E Carlson; Andrew S Greene
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-12-24       Impact factor: 4.733

6.  Genome-wide map of proximity linkage to renin proximal promoter in rat.

Authors:  Timothy J Stodola; Pengyuan Liu; Yong Liu; Andrew K Vallejos; Aron M Geurts; Andrew S Greene; Mingyu Liang
Journal:  Physiol Genomics       Date:  2018-03-09       Impact factor: 3.107

7.  Bone marrow mononuclear cell angiogenic competency is suppressed by a high-salt diet.

Authors:  Jamie R Karcher; Andrew S Greene
Journal:  Am J Physiol Cell Physiol       Date:  2013-11-20       Impact factor: 4.249

Review 8.  The ACE2/Angiotensin-(1-7)/MAS Axis of the Renin-Angiotensin System: Focus on Angiotensin-(1-7).

Authors:  Robson Augusto Souza Santos; Walkyria Oliveira Sampaio; Andreia C Alzamora; Daisy Motta-Santos; Natalia Alenina; Michael Bader; Maria Jose Campagnole-Santos
Journal:  Physiol Rev       Date:  2018-01-01       Impact factor: 37.312

Review 9.  Targeting stem cell niches and trafficking for cardiovascular therapy.

Authors:  Nicolle Kränkel; Gaia Spinetti; Silvia Amadesi; Paolo Madeddu
Journal:  Pharmacol Ther       Date:  2010-10-20       Impact factor: 12.310

10.  RAS-Mediated Adaptive Mechanisms in Cardiovascular Tissues: Confounding Factors of RAS Blockade Therapy and Alternative Approaches.

Authors:  Rukhsana Gul; Maya Ramdas; Chirag H Mandavia; James R Sowers; Lakshmi Pulakat
Journal:  Cardiorenal Med       Date:  2012-10-27       Impact factor: 2.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.